Highlights
NASDAQ: IDXG       Interpace Diag Group
Last Price Today's Change   Day's Range   Trading Volume
3.725   +0.035 (0.95%)  3.69 - 3.87  30,154

Overview

 
Avg Volume (4 weeks):2,693,565
4 Weeks Range:2.91 - 5.72
4 Weeks Price Volatility (%):
29.00%
52 Weeks Range:0.381 - 11.00
52 Weeks Price Volatility (%):
31.49%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Interpace Diagnostics Group Inc is engaged in developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for patient diagnosis and management. The company currently has three commercialized molecular tests PancraGen for the diagnosis and prognosis of pancreatic cancer from pancreatic cysts, ThyGenX, for the diagnosis of thyroid cancer from thyroid nodules utilizing a next generation sequencing assay and, ThyraMIR for the diagnosis of thyroid cancer from thyroid nodules utilizing a proprietary gene expression assay.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2246  3531  466  3145 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 1.38+1.38 
 ISIG 1.38+0.434 
 OAS 0.155-0.014 
 AMD 79.27-2.96 
 NIO 27.41+1.40 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 XOG 0.271-0.062 
 AAPL 116.05+1.00 
 SNAP 41.90+0.63